Skip to main content
HairCited

Omega-3 Fatty Acids के लिए Telogen Effluvium

B

11 अध्ययनों पर आधारित, में कुल 317 प्रतिभागियों के साथ। 8/11 अध्ययन सकारात्मक प्रभाव दिखाते हैं।

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Domega\u002D3\u0026condition\u003Dtelogen\u002Deffluvium'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

निष्कर्ष

Moderate evidence suggests that omega-3 fatty acids may help support hair recovery in telogen effluvium, though the research base is limited and they are usually studied alongside other nutrients.

  • 8 out of 11 studies show positive effects, but total sample size is small (317 participants)
  • Often studied as part of multi-nutrient supplement formulations
  • No large-scale RCTs specifically for omega-3 and telogen effluvium
  • May support recovery through anti-inflammatory and nutritional mechanisms

Key Study Findings

review
Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations.
Dose: Oral minoxidil: women 1.25 mg/day starting dose (range 0.625-5 mg/day); men 2.5 mg/day (range 1.25-5 बनाम: Placebo प्रभाव: Comparable efficacy to topical minoxidil; hypertrichosis 24%, shedding 16-22%, peripheral edema 2% None
narrative review
Herbal Remedies for Hair Loss: A Review of Efficacy and Safety.
Dose: varies by remedy and study बनाम: Placebo प्रभाव: None None
scoping_review n=16
A Scoping Review of Exosome Delivery Applications in Hair Loss.
Dose: variable; exosomes predominantly from mesenchymal stem cells (MSCs) बनाम: Placebo प्रभाव: None None
review
The Use of Light-Based Therapies in the Treatment of Alopecia.
Dose: Low-level light therapy (LLLT) various devices and wavelengths; combined with minoxidil or finasteri बनाम: Placebo प्रभाव: LLLT improves hair density in AGA; potential to prolong anagen phase in telogen effluvium; may promo None
Cohort n=200 Open-label
Iron Supplementation May Improve the Patient's Level of Satisfaction in Not-Low-Ferritin Telogen Effluvium: A Real-Life …
Dose: high dose elemental iron (dose unspecified) बनाम: Placebo प्रभाव: Patients with baseline ferritin ≥50 ng/ml mostly 'very satisfied'; patients with ferritin <50 ng/ml None
clinical trial (open-label)
Clinical study on the efficacy and tolerability of a topical regenerative treatment in patients with …
Dose: None बनाम: Placebo प्रभाव: None None

Key Statistics

11

अध्ययन

317

प्रतिभागी

Positive

B

ग्रेड

Referenced Papers

American journal of … 2026 1 उद्धरण
Skin appendage disorders 2025 7 उद्धरण
Journal of cosmetic … 2022 30 उद्धरण
Acta dermatovenerologica Croatica … 2016 6 उद्धरण
Therapeutische Umschau. Revue … 2002 4 उद्धरण
Dermatologic clinics 1993 38 उद्धरण

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

सामान्य रूप से उपयोग की जाने वाली खुराकें

general:
250-500 mg EPA+DHA/day
hairloss:
1,000-2,000 mg/day

अधिकतम सीमा: 3,000 mg/day EPA+DHA

अनुसंधान में अध्ययन की गई खुराकें

खुराक अवधि प्रभाव N
Oral minoxidil: women 1.25 mg/day starting dose (range 0.625-5 mg/day); men 2.5 mg/day (range 1.25-5 -- Positive --
varies by remedy and study -- Positive --
variable; exosomes predominantly from mesenchymal stem cells (MSCs) -- Positive 16
Low-level light therapy (LLLT) various devices and wavelengths; combined with minoxidil or finasteri -- Positive --
high dose elemental iron (dose unspecified) -- Positive 200
None -- Positive --
None -- Neutral 100
psychiatric and dermatological management -- Neutral 1

सेवन का सर्वोत्तम समय: With meals containing fat for optimal absorption; split doses if over 1,000 mg

Safety & Side Effects

रिपोर्ट किए गए दुष्प्रभाव

  • Fishy aftertaste or burping
  • Mild gastrointestinal upset (nausea, diarrhea)
  • Possible increased bleeding time at high doses
  • Unpleasant body odor at very high doses

ज्ञात अंतःक्रियाएँ

  • Anticoagulants (warfarin) and antiplatelet drugs (may increase bleeding risk)
  • Blood pressure medications (additive hypotensive effect)
  • Orlistat (reduces omega-3 absorption)

सहनीय अधिकतम सेवन: 3,000 mg/day EPA+DHA

कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।

Frequently Asked Questions

Does Omega-3 Fatty Acids help with Telogen Effluvium?
Based on 11 studies with 317 participants, there is moderate evidence from clinical studies that Omega-3 Fatty Acids may support Telogen Effluvium management. Our evidence grade is B (Good Evidence).
How much Omega-3 Fatty Acids should I take for Telogen Effluvium?
Studies have used various dosages. A commonly studied range is 250-500 mg EPA+DHA/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3 Fatty Acids?
Reported side effects may include Fishy aftertaste or burping, Mild gastrointestinal upset (nausea, diarrhea), Possible increased bleeding time at high doses, Unpleasant body odor at very high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 Fatty Acids and Telogen Effluvium?
We rate the evidence as Grade B (Good Evidence). This rating is based on 11 peer-reviewed studies with 317 total participants. The overall direction of effect is positive.

Related Evidence

इसके लिए अन्य सामग्री Telogen Effluvium

Omega-3 Fatty Acids अन्य स्वास्थ्य स्थितियों के लिए

FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।